707 completed, 49 unknown, 40 recruiting, 39 terminated. 892 Phase 3, 71 Phase 2.
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma CHF5993 100/6/12.5 μg pMDI HFA-152a, Seretide Evohaler - Asthma | Phase 3 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | 700 | 2026-11-16 | 2026-10-05 |
| Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA) N0783, Alenia® (Formoterol 6 mcg / Budesonide 200 mcg) - Moderate Asthma | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-10-01 | 2026-10-23 | |
| A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma tilrekimig, Placebo - Asthma | Phase 3 | Recruiting | Pfizer | 1100 | 2026-09-30 | 2026-10-09 |
| A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a) HFA-152a, HFA-134a - Asthma | Phase 3 | Recruiting | GlaxoSmithKline | 110 | 2026-09-01 | 2026-09-30 |
| A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2) GSK5784283, Placebo, Standard of care - Asthma | Phase 3 | Recruiting | GlaxoSmithKline | 370 | 2026-08-27 | 2026-09-30 |
| A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1) GSK5784283, Placebo, Standard of care - Asthma | Phase 3 | Recruiting | GlaxoSmithKline | 514 | 2026-08-27 | 2026-09-25 |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma tilrekimig, Placebo - Asthma | Phase 3 | Recruiting | Pfizer | 1100 | 2026-08-20 | 2026-10-06 |
| Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis Rupatifen Fumarate Capsules, Rupatadine Fumarate Tablets, Rupatifen Fumarate Capsules Placebo - Seasonal Allergic Rhinitis | Phase 3 | Recruiting | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. | 550 | 2026-08-18 | 2026-09-09 |
| Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis Stapokibart, Placebo - Seasonal Allergic Rhinitis (SAR) | Phase 3 | Recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 136 | 2026-08-13 | 2026-09-03 |
| A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 3 | Active not recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 220 | 2026-08-11 | 2026-10-22 |
| A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149 - Asthma | Phase 3 | Recruiting | Novartis Pharmaceuticals | 188 | 2026-08-04 | 2026-10-15 |
| Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Benralizumab - Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Phase 3 | Recruiting | AstraZeneca | 230 | 2026-07-24 | 2026-09-22 |
| Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists Experimental: Participant Group CHF 5993 pMDI HFA-152a, Active Comparator: CHF 1535 100/6 μg pMDI HFA-134a - Asthma | Phase 3 | Recruiting | Chiesi Farmaceutici S.p.A. | 554 | 2026-06-26 | 2026-07-08 |
| A Study of Depemokimab in Participants of 6 to 11 Years of Age Depemokimab - Asthma | Phase 3 | Recruiting | GlaxoSmithKline | 34 | 2026-06-25 | 2026-08-26 |
| Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma Beclometasone Dipropionate and Formoterol Inhalation Aerosol, FOSTER® - Asthma (Diagnosis) | Phase 3 | Recruiting | Lunan Better Pharmaceutical Co., LTD. | 416 | 2026-06-08 | 2026-08-17 |
| "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" Prednisolone, Placebo - Hypersensitivity Pneumonitis | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 120 | 2026-06-01 | 2025-10-07 |
| A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma Depemokimab, Placebo - Asthma | Phase 3 | Recruiting | GlaxoSmithKline | 456 | 2026-03-13 | 2026-08-17 |
| Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil Administration of investigation of Eurofarma drug, Administration of Comparator - Allergic Rhinitis | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-03-01 | 2025-12-18 | |
| A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma Dupilumab Prefilled Syringe, Placebo Injection - Asthma Control | Phase 3 | Recruiting | Université de Sherbrooke | 150 | 2026-01-29 | 2026-10-02 |
| Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab Tezepelumab - Severe Asthma | Phase 3 | Recruiting | AstraZeneca | 400 | 2026-01-28 | 2026-09-03 |
Showing 20 of 892. Sign in to see all of them.
Asthma (605) · Rhinitis, Allergic, Seasonal (127) · Rhinitis, Allergic (115) · Rhinitis, Allergic, Perennial (82) · Hypersensitivity (34) · Lung Diseases (24) · Rhinitis (21) · Lung Diseases, Obstructive (18) · Respiratory Tract Diseases (18) · Bronchial Diseases (15) · Pulmonary Eosinophilia (12) · Asthma, Exercise-Induced (11) · Dust Mite Allergy (11) · Aspergillosis, Allergic Bronchopulmonary (10) · Pulmonary Disease, Chronic Obstructive (10)
Hypersensitivity, Immediate (891) · Immune System Diseases (888) · Respiratory Tract Diseases (874) · Hypersensitivity (858) · Bronchial Diseases (601) · Lung Diseases (592) · Lung Diseases, Obstructive (588) · Otorhinolaryngologic Diseases (289) · Nose Diseases (285) · Rhinitis (261) · Rhinitis, Allergic (164) · Pathological Conditions, Signs and Symptoms (61) · Infections (42) · Respiratory Tract Infections (38)
Budesonide (78) · Fluticasone (66) · montelukast (52) · Albuterol (50) · Budesonide, Formoterol Fumarate Drug Combination (48) · Formoterol Fumarate (42) · Mometasone Furoate (41) · Beclomethasone (40) · ciclesonide (38) · Salmeterol Xinafoate (28) · Fluticasone-Salmeterol Drug Combination (25) · benralizumab (22) · fluticasone furoate (22) · Omalizumab (21) · azelastine (19)
AstraZeneca (132) · GlaxoSmithKline (85) · Organon and Co (75) · Teva Branded Pharmaceutical Products R&D, Inc. (30) · Novartis Pharmaceuticals (23) · Chiesi Farmaceutici S.p.A. (22) · Sanofi (20) · Sumitomo Pharma America, Inc. (20) · Boehringer Ingelheim (19) · Milton S. Hershey Medical Center (17) · ALK-Abelló A/S (15) · Meda Pharmaceuticals (14) · Eurofarma Laboratorios S.A. (10) · EMS (9) · Post Graduate Institute of Medical Education and Research, Chandigarh (9)
United States (360) · Germany (136) · Poland (125) · Canada (119) · Spain (93) · Russia (89) · Argentina (87) · United Kingdom (86) · Hungary (79) · France (78) · Japan (77) · Ukraine (74) · Italy (73) · Mexico (71) · China (69)
Catherine Bonuccelli (11) · Elliot Israel, MD (6) · Lewis M Fredane, MD (6)
PMID 36472162, PMID 27881132, PMID 31319851, PMID 32926419, PMID 39393433, PMID 29174062, PMID 30954640, PMID 32180164, PMID 22329608, PMID 24966061, PMID 26369589, PMID 26498386, PMID 26612545, PMID 26704701, PMID 29536781, PMID 29656145, PMID 30802500, PMID 31047111, PMID 31251094, PMID 31447130, PMID 31760132, PMID 33217063, PMID 33223095, PMID 34098955, PMID 35287231, PMID 35636689, PMID 36356712, PMID 36702146, PMID 19449366, PMID 19995138, PMID 20075384, PMID 20819318, PMID 20835586, PMID 21439168, PMID 22737708, PMID 22938706, PMID 24314123, PMID 24838406, PMID 25682232, PMID 25724847, PMID 26364765, PMID 27087007, PMID 27216137, PMID 27616196, PMID 27912982, PMID 28069068, PMID 28624608, PMID 29409951, PMID 29949045, PMID 30027002
2015 (15), 2016 (13), 2023 (12), 2017 (10), 2009 (9), U10HL098115 (7), 2014 (6), 2018 (6), U10HL074073 (5), U10HL074204 (5), U10HL074208 (5), U10HL074212 (5), U10HL074218 (5), U10HL074225 (5), U10HL074227 (5)